SEI INVESTMENTS CO

Position in PGEN — Precigen, Inc.

CIK 350894 OAKS, PA

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$723,226

+$677,565 QoQ

Shares Held

126,882

+975.4% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 210 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. PGEN ranks #98 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$723,226	126,882	+975.4%	Shares	Sole	2026-08-14
2026-03-31	$45,661	11,799	-75.5%	Shares	Sole	2026-05-13
2025-12-31	$200,934	48,071	-34.2%	Shares	Defined	2026-02-13
2025-09-30	$240,271	73,031	-93.0%	Shares	Defined	2025-11-13
2023-06-30	$1,201,942	1,045,167	0.0%	Shares	Sole	2023-08-11
2023-03-31	$1,107,877	1,045,167	+27.9%	Shares	Sole	2023-05-12
2022-12-31	$1,242,318	817,315	-1.9%	Shares	Sole	2023-02-10
2022-09-30	$1,766,627	833,315	+2.0%	Shares	Defined	2022-11-14
2022-06-30	$1,095,202	817,315	0.0%	Shares	Sole	2022-08-15
2022-03-31	$1,724,534	817,315	+5.9%	Shares	Sole	2022-05-13
2021-12-31	$2,862,313	771,513	+98.4%	Shares	Sole	2022-02-14
2021-09-30	$1,940,551	388,888	0.0%	Shares	Sole	2021-11-12
2021-06-30	$2,535,549	388,888	0.0%	Shares	Sole	2021-08-06
2021-03-31	$2,679,438	388,888	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.